OncoHost Launches NSCLC Test in the U.S.
OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.
Read MorePosted by Andy Lundin | Feb 1, 2023 | Immunoassay Reagents & test Kits, Lung Cancer |
OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 24, 2023 | Lung Cancer |
Thermo Fisher Scientific is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic test for Tagrisso.
Read MorePosted by Andy Lundin | Jan 23, 2023 | Immunoassay Reagents & test Kits, Lung Cancer, Sequencing Systems |
The liquid biopsy ctDx FIRST test is FDA approved as a companion diagnostic for advanced non-small cell lung cancer (NSCLC) patients.
Read MorePosted by Andy Lundin | Jan 11, 2023 | Dementias & Alzheimer’s |
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read More